- Vetter successfully brought eight customer drugs to market after supporting them through the development phases in 2023
- As an established leader in commercial fill and finish, Vetter has evolved as a trusted provider of drug product development services.
- New molecules candidates brought to Vetter in the clinic receive strategic counsel and experienced support to guide their path to market and beyond.
Vetter, the Ravensburg, Germany-headquartered Contract Development and Manufacturing Organisation (CDMO), has announced successful commercial launch of eight customer products in 2023.
The drug products that reached the world market are used in oncology and to treat autoimmune and cardiovascular diseases, among others. Their nature and administration vary widely, ranging from emergency medications to long-term and life-enhancing therapies for patients. The drugs also vary in delivery methods, which include self-administration for at-home care and administration by healthcare professionals.
“Bringing a promising therapy through the clinical phase to market readiness and launch is a challenging journey that culminates years of development work. Our holistic development service offerings build on one another and become interlinked,” said Dr. Claus Feussner, Senior Vice President Vetter Development Service.
“This allows us to support our customer’s products throughout the entire development cycle to commercialisation and beyond. Our individualised capabilities have allowed us to support more than 50 market launches over the past five years.”
The CDMO is currently supporting more than 200 projects in early and late clinical phases as well as life-cycle development. With two dedicated clinical manufacturing sites in Skokie, USA, and Rankweil, Austria, the pharmaceutical service provider supports clinical batch production for in-human trials in early development. Late-stage development, including process design, method transfer and handover to quality and production for commercial manufacturing and launch, takes place in Ravensburg, Germany.
Overview of outsourcing trends 
